1 min read •
The biologization of the world
There is still little importance in white or industrial biotechnology compared to medical biotechnology. A recent Arthur D. Little study come to the conclusion that the industrial proportion in chemical sales in 2007 has merely been three to four per cent, what corresponds to a volume of 50 to 75 billion US-Dollar. In 2020 the proportion is expected to soar up to one third turning over an amount of 300 billion US-Dollar within this segment of the biotech-industry.
There is still little importance in white or industrial biotechnology compared to medical biotechnology. A recent Arthur D. Little study come to the conclusion that the industrial proportion in chemical sales in 2007 has merely been three to four per cent, what corresponds to a volume of 50 to 75 billion US-Dollar. In 2020 the proportion is expected to soar up to one third turning over an amount of 300 billion US-Dollar within this segment of the biotech-industry.
RELATED INFORMATION
Healthcare Innovation
The discovery, development, manufacturing, delivery, and sales of specialty pharmaceuticals require new and advanced tools, technologies, and expertise. While these structural changes present…
Managing Technology Discontinuities for Competitive Advantage
In this high–tech era, technology discontinuities occur in every industry sector. Digital mobile telephony, computer optical storage systems, high performance polymers, biotechnology, and genetic…
Arthur D. Little announces principal promotions
Jim Chauvapun has been promoted from Manager to Principal in the Healthcare and Life Sciences practice in Boston. Over the past four years with ADL, Jim has established a proven track record of…